Skip to main content
Top
Published in: Journal of Hepato-Biliary-Pancreatic Sciences 5/2009

01-09-2009 | Case report of interest

A rare surgical case of multiple liver resections for recurrent liver metastases from pancreatic gastrinoma: liver and vena cava resection

Authors: Silvia Pachera, Yukihiro Yokoyama, Hideki Nishio, Koji Oda, Tomoki Ebata, Tsuyoshi Igami, Tetsuya Abe, Yuji Shingu, Masato Nagino

Published in: Journal of Hepato-Biliary-Pancreatic Sciences | Issue 5/2009

Login to get access

Abstract

Pancreatic gastrinoma is a rare non-β islet cell tumor. Approximately 60% of gastrinomas are malignant; despite the fact that they are usually slow growing, liver metastases have a major impact on prognosis. Most authors have advocated aggressive surgical management as being the only potentially curative therapy to improve survival as well as to provide outstanding relief from symptoms. We present a case of a 57-year-old man referred to our hospital with a diagnosis of liver metastases from pancreatic gastrinoma, with suspected involvement of the inferior vena cava (IVC). At the age of 37 years, he was diagnosed in his local hospital as having a pancreatic gastrinoma, with liver metastases, and he underwent distal pancreatectomy, splenectomy and enucleation of liver metastases. A liver tumor recurred twice, 7 and 9 years after the first surgery, for which double liver resections were performed: the first time he underwent enucleation of multiple liver metastases in segments II, III, IV, V, VI, VII and VIII, with resection of the right hepatic vein and partially resection of the diaphragm; the second time he underwent enucleation of multiple liver metastases in segments II, III, IV, and V. In our hospital, 8 years after the last surgery, the patient underwent right extended trisectionectomy, resection of segment I, combined resection of the IVC, and partial removal of the diaphragm. To the best of our knowledge, from a review of the literature, this is the first case to achieve successful long-term survival through aggressive surgical management of this type of metastatic endocrine tumor. The patient described here is still alive, free of disease and leading a normal life, 20 years after the initial diagnosis and 3 years after the last surgery.
Literature
1.
go back to reference Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol. 2005;19:753–81.PubMedCrossRef Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol. 2005;19:753–81.PubMedCrossRef
2.
go back to reference Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associate with islet cell tumours of the pancreas. Ann Surg. 1955;142:709–23.PubMedCrossRef Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associate with islet cell tumours of the pancreas. Ann Surg. 1955;142:709–23.PubMedCrossRef
3.
go back to reference Jensen R, Niederle B, Mitry E, Ramage JK, Steinmuller T, Lewington V, et al. Gastrinoma (duodenal and pancreatic). Neuroendocrinology. 2006;84:173–82.PubMedCrossRef Jensen R, Niederle B, Mitry E, Ramage JK, Steinmuller T, Lewington V, et al. Gastrinoma (duodenal and pancreatic). Neuroendocrinology. 2006;84:173–82.PubMedCrossRef
4.
go back to reference Norton JA, Doherty GM, Fraker DL, Alexander R, Doppman JL, Venzon DJ, et al. Surgical treatment of localized gastrinoma within the liver: a prospective study. Surgery. 1998;124:1145–52.PubMedCrossRef Norton JA, Doherty GM, Fraker DL, Alexander R, Doppman JL, Venzon DJ, et al. Surgical treatment of localized gastrinoma within the liver: a prospective study. Surgery. 1998;124:1145–52.PubMedCrossRef
5.
go back to reference Imamura M, Komoto I, Ota S. Changing treatment strategy for gastrinoma in patients with Zollinger–Ellison syndrome. World J Surg. 2006;30:1–11.PubMedCrossRef Imamura M, Komoto I, Ota S. Changing treatment strategy for gastrinoma in patients with Zollinger–Ellison syndrome. World J Surg. 2006;30:1–11.PubMedCrossRef
6.
go back to reference Ohshio G, Hosotani R, Imamura M, Sakahara H, Ochi J, Kubota N. Gastrinoma with multiple liver metastases: effectiveness of decarbazine (DTIC) therapy. J Hepatobiliary Pancreat Surg. 1998;5:339–43.PubMedCrossRef Ohshio G, Hosotani R, Imamura M, Sakahara H, Ochi J, Kubota N. Gastrinoma with multiple liver metastases: effectiveness of decarbazine (DTIC) therapy. J Hepatobiliary Pancreat Surg. 1998;5:339–43.PubMedCrossRef
7.
go back to reference Teh SH, Deveney C, Sheppard BC. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable? Am J Surg. 2007;193:610–3.PubMedCrossRef Teh SH, Deveney C, Sheppard BC. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable? Am J Surg. 2007;193:610–3.PubMedCrossRef
9.
go back to reference Norton JA, Fraker DL, Alexander HR, Gibril F, Liewehr DJ, Venzon DJ, et al. Surgery increases survival in patients with gastrinoma. Ann Surg. 2006;244:410–9.PubMed Norton JA, Fraker DL, Alexander HR, Gibril F, Liewehr DJ, Venzon DJ, et al. Surgery increases survival in patients with gastrinoma. Ann Surg. 2006;244:410–9.PubMed
10.
go back to reference Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, et al. An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumours. Ann Surg. 2006;244:845–53.PubMedCrossRef Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, et al. An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumours. Ann Surg. 2006;244:845–53.PubMedCrossRef
11.
go back to reference Anlauf M, Garbrecht N, Hennop T, Schmitt A, Schlenger R, Raffel A, et al. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol. 2006;12:5440–6.PubMed Anlauf M, Garbrecht N, Hennop T, Schmitt A, Schlenger R, Raffel A, et al. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol. 2006;12:5440–6.PubMed
12.
go back to reference Japan Pancreatoduodenectomy Study Group. Surgical management of endocrine tumor of the pancreas in Japan. J Hepatobiliary Pancreat Surg. 1997;4:295–303.CrossRef Japan Pancreatoduodenectomy Study Group. Surgical management of endocrine tumor of the pancreas in Japan. J Hepatobiliary Pancreat Surg. 1997;4:295–303.CrossRef
13.
go back to reference Chang F, Chandra A, Culora G, Mahadeva U, Meenan J, Herbert A. Cytologic diagnosis of pancreatic endocrine tumors by endoscopic ultrasound-guided fine-needle aspiration: a review. Diagn Cytopathol. 2006;34:649–58.PubMedCrossRef Chang F, Chandra A, Culora G, Mahadeva U, Meenan J, Herbert A. Cytologic diagnosis of pancreatic endocrine tumors by endoscopic ultrasound-guided fine-needle aspiration: a review. Diagn Cytopathol. 2006;34:649–58.PubMedCrossRef
14.
go back to reference Debray MP, Geoffroy O, Laissy JP, Lebtahi R, Silbermann-Hoffman O, Feugeas MCH, et al. Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol. 2001;74:1065–70.PubMed Debray MP, Geoffroy O, Laissy JP, Lebtahi R, Silbermann-Hoffman O, Feugeas MCH, et al. Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol. 2001;74:1065–70.PubMed
15.
go back to reference Que FG, Sarmiento JM, Nagorney DM. Hepatic surgery for metastatic gastrointestinal neuroendocrine tumours. Cancer Control. 2002;9:67–79.PubMed Que FG, Sarmiento JM, Nagorney DM. Hepatic surgery for metastatic gastrointestinal neuroendocrine tumours. Cancer Control. 2002;9:67–79.PubMed
16.
go back to reference Norton JA, Jensen RT. Role of surgery in Zollinger–Ellison syndrome. Am Coll Surg. 2007;205:s34–7.CrossRef Norton JA, Jensen RT. Role of surgery in Zollinger–Ellison syndrome. Am Coll Surg. 2007;205:s34–7.CrossRef
17.
go back to reference House MG, Cameron JL, Lillimoe MD, Schulick RD, Choti MA, Hansel DE, et al. Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. J Gastr Surg. 2006;1:138–45.CrossRef House MG, Cameron JL, Lillimoe MD, Schulick RD, Choti MA, Hansel DE, et al. Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. J Gastr Surg. 2006;1:138–45.CrossRef
18.
go back to reference Hodul P, Malafa MM, Choi J, Kvlos L. The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas. Cancer Control. 2006;13:61–71.PubMed Hodul P, Malafa MM, Choi J, Kvlos L. The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas. Cancer Control. 2006;13:61–71.PubMed
19.
go back to reference Yoshimi F, Asato Y, Suzuki A, Kiyoshima M, Shioyama Y, Shioyama Y, et al. Long-term survival after repeat resections of metastases in liver, lung and stomach from sigmoid colon cancer: report of a case. Surg Tod. 2007;37:53–60.CrossRef Yoshimi F, Asato Y, Suzuki A, Kiyoshima M, Shioyama Y, Shioyama Y, et al. Long-term survival after repeat resections of metastases in liver, lung and stomach from sigmoid colon cancer: report of a case. Surg Tod. 2007;37:53–60.CrossRef
21.
go back to reference Azimuddin K, Chamberlain RS. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am. 2001;81:511–25.PubMedCrossRef Azimuddin K, Chamberlain RS. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am. 2001;81:511–25.PubMedCrossRef
22.
go back to reference Norton JA, Sugarbaker PH, Doppman JL, Wesley RA, Maton PN, Gardner JD, Jensen RT. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg. 1986;203:352–9.PubMedCrossRef Norton JA, Sugarbaker PH, Doppman JL, Wesley RA, Maton PN, Gardner JD, Jensen RT. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg. 1986;203:352–9.PubMedCrossRef
23.
go back to reference Kuehnl A, Schmidt M, Hornung HM, Graser A, Jauch KW, Kopp R. Resection of malignant tumours invading the vena cava: perioperative complications and long-term follow-up. J Vasc Surg. 2007;46:533–40.PubMedCrossRef Kuehnl A, Schmidt M, Hornung HM, Graser A, Jauch KW, Kopp R. Resection of malignant tumours invading the vena cava: perioperative complications and long-term follow-up. J Vasc Surg. 2007;46:533–40.PubMedCrossRef
24.
go back to reference Didier D, Racle A, Etievent JF, Weill F. Tumour thrombus of the inferior vena cava secondary to malignant abdominal neoplasms: US and CT evaluation. Radiology. 1987;162:83–9.PubMed Didier D, Racle A, Etievent JF, Weill F. Tumour thrombus of the inferior vena cava secondary to malignant abdominal neoplasms: US and CT evaluation. Radiology. 1987;162:83–9.PubMed
25.
go back to reference Maeba T, Okano K, Mori S, Karasawa Y, Goda F, Wakabayashi H, et al. Extent of pathologic invasion of the inferior vena cava in resected liver cancer compared with possible caval invasion diagnosed by preoperative images. J Hepatobiliary Pancreat Surg. 2000;7:299–305.PubMedCrossRef Maeba T, Okano K, Mori S, Karasawa Y, Goda F, Wakabayashi H, et al. Extent of pathologic invasion of the inferior vena cava in resected liver cancer compared with possible caval invasion diagnosed by preoperative images. J Hepatobiliary Pancreat Surg. 2000;7:299–305.PubMedCrossRef
Metadata
Title
A rare surgical case of multiple liver resections for recurrent liver metastases from pancreatic gastrinoma: liver and vena cava resection
Authors
Silvia Pachera
Yukihiro Yokoyama
Hideki Nishio
Koji Oda
Tomoki Ebata
Tsuyoshi Igami
Tetsuya Abe
Yuji Shingu
Masato Nagino
Publication date
01-09-2009
Publisher
Springer Japan
Published in
Journal of Hepato-Biliary-Pancreatic Sciences / Issue 5/2009
Print ISSN: 1868-6974
Electronic ISSN: 1868-6982
DOI
https://doi.org/10.1007/s00534-009-0055-0

Other articles of this Issue 5/2009

Journal of Hepato-Biliary-Pancreatic Sciences 5/2009 Go to the issue